Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2007-04-17
2007-04-17
Tsang, Cecilia J. (Department: 1654)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S133000, C530S300000, C530S333000, C514S002600, C514S563000
Reexamination Certificate
active
10474378
ABSTRACT:
Novel compounds of general formula (I), are provided with inhibitory properties for the type B botulism toxin activity, along with methods for preparation thereof and corresponding pharmaceutical compositions.
REFERENCES:
patent: 4407794 (1983-10-01), Roques et al.
patent: 4513009 (1985-04-01), Roques et al.
patent: 4618708 (1986-10-01), Roques et al.
patent: 4714757 (1987-12-01), Gordon et al.
patent: 4738803 (1988-04-01), Roques et al.
patent: 4985406 (1991-01-01), Charpentier et al.
patent: 5190921 (1993-03-01), Roques et al.
patent: 5466672 (1995-11-01), Kushnaryov et al.
patent: 5491169 (1996-02-01), Roques et al.
patent: 5591891 (1997-01-01), Fournie-Zaluski et al.
patent: 5741781 (1998-04-01), Roques et al.
patent: 5801274 (1998-09-01), Fournie-Zaluski et al.
patent: 6136842 (2000-10-01), Deprez et al.
patent: 6180611 (2001-01-01), Montana et al.
patent: 6340708 (2002-01-01), Llorens-Cortes et al.
patent: 6391866 (2002-05-01), Roques et al.
patent: 6518260 (2003-02-01), Fournie-Zaluski et al.
patent: 6716852 (2004-04-01), Roques et al.
C. David-Basei, et al. J. Labelled Cpd. Radiopharm. (2001), 44, pp. 89-98.
A.D. Baxter, et al. Bioorg. Med. Chem. Letters (1997) 7(21), pp. 2765-2770.
E.J. Schantz and E.A. Johnson. Microbiol. Rev. (1992) 56(1), pp. 80-99.
L.E. Davis. West. J. Med. (1993) 158, pp. 25-29.
O. Resetto, et al. Toxicon (2001) 29, pp. 27-41.
C.G. Knight, et al. FEBS Letters (1992) 296(3), pp. 2634-266.
R.J. Bastin, et al. Org. Proc. Res. Develop. (2000) 4, pp. 427-435.
L. Martin et al. J. Med. Chem. (1999) 42, pp. 515-525.
Anne Christine
Fournie-Zaluski Marie-Claude
Roques Bernard
Turcaud Serge
Centre National de la Recherche Scientifique (C.N.R.C.)
Institut National de la Sante et de la Recherche Medicale (INSER
Kosar Andrew D.
Schulman B. Aaron
Stites & Harbison PLLC
LandOfFree
Type B botulism toxin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type B botulism toxin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type B botulism toxin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3735983